What held HUM Flatter Me back "2 inches" is best-case the trial's average was much smaller (~ inch), from just 20 women
Getting the right dose is important for safe and effective treatment
In addition, despite a lack of evidence of the parasympathetic innervation of WAT (108, 109), it can still affect WAT through multiple pathways, and studies have suggested that reduced parasympathetic activity is associated with obesity (110)
J Enzyme Inhib Med Chem 31(S2):162166 [DOI] [PubMed] [Google Scholar] Ekinci Akdemir FN, Albayrak M, alik M, Bayir Y, Gulin (2017) The protective effects of p-coumaric acid on acute liver and kidney damages induced by cisplatin
Compounded tirzepatide is a dual GIP/GLP-1 agonist it works through two incretin pathways involved in appetite, satiety, and metabolic signaling
According to Grand View Research, specifically for GLP-1 weight-loss, the market size in 2025 is about $20.86 billion, expected to grow to $48.84 billion by 2030, with a CAGR of ~18.5%